IDR 2430.0
(-1.62%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 3255.8 Billion IDR | -6.45% |
2022 | 3480.26 Billion IDR | 20.01% |
2021 | 2899.96 Billion IDR | 2.36% |
2020 | 2833.1 Billion IDR | -17.65% |
2019 | 3440.4 Billion IDR | 9.67% |
2018 | 3136.94 Billion IDR | 3.81% |
2017 | 3021.94 Billion IDR | 8.29% |
2016 | 2790.55 Billion IDR | 15.14% |
2015 | 2423.6 Billion IDR | 7.26% |
2014 | 2259.45 Billion IDR | 15.27% |
2013 | 1960.06 Billion IDR | 12.25% |
2012 | 1746.11 Billion IDR | 13.59% |
2011 | 1537.22 Billion IDR | 17.95% |
2010 | 1303.33 Billion IDR | 5.96% |
2009 | 1230.02 Billion IDR | 17.01% |
2008 | 1051.17 Billion IDR | 9.61% |
2007 | 959.03 Billion IDR | 19.15% |
2006 | 804.88 Billion IDR | 10.06% |
2005 | 731.33 Billion IDR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 763.25 Billion IDR | -15.98% |
2024 Q3 | 774.45 Billion IDR | 41.13% |
2024 Q2 | 700.13 Billion IDR | -8.27% |
2023 Q2 | 880.4 Billion IDR | -1.72% |
2023 Q1 | 895.76 Billion IDR | -20.33% |
2023 FY | 3255.8 Billion IDR | -6.45% |
2023 Q4 | 908.39 Billion IDR | 14.83% |
2023 Q3 | 791.05 Billion IDR | -10.15% |
2022 Q1 | 698.93 Billion IDR | -0.64% |
2022 FY | 3480.26 Billion IDR | 20.01% |
2022 Q2 | 811.95 Billion IDR | 16.17% |
2022 Q4 | 1124.32 Billion IDR | 33.05% |
2022 Q3 | 845.05 Billion IDR | 4.08% |
2021 Q2 | 779.87 Billion IDR | 32.85% |
2021 FY | 2899.96 Billion IDR | 2.36% |
2021 Q4 | 703.44 Billion IDR | -15.21% |
2021 Q3 | 829.58 Billion IDR | 6.37% |
2021 Q1 | 587.05 Billion IDR | -15.8% |
2020 Q1 | 604.02 Billion IDR | -30.05% |
2020 FY | 2833.1 Billion IDR | -17.65% |
2020 Q2 | 751.98 Billion IDR | 24.5% |
2020 Q3 | 779.85 Billion IDR | 3.71% |
2020 Q4 | 697.23 Billion IDR | -10.59% |
2019 Q4 | 863.54 Billion IDR | -10.05% |
2019 Q2 | 859.56 Billion IDR | 13.51% |
2019 Q1 | 757.23 Billion IDR | -7.99% |
2019 FY | 3440.4 Billion IDR | 9.67% |
2019 Q3 | 960.06 Billion IDR | 11.69% |
2018 FY | 3136.94 Billion IDR | 3.81% |
2018 Q4 | 823.02 Billion IDR | -6.76% |
2018 Q3 | 882.67 Billion IDR | 20.53% |
2018 Q2 | 732.35 Billion IDR | 4.79% |
2018 Q1 | 698.88 Billion IDR | -9.45% |
2017 FY | 3021.94 Billion IDR | 8.29% |
2017 Q1 | 663.75 Billion IDR | -5.59% |
2017 Q2 | 725.81 Billion IDR | 9.35% |
2017 Q3 | 860.54 Billion IDR | 18.56% |
2017 Q4 | 771.83 Billion IDR | -10.31% |
2016 Q1 | 608.28 Billion IDR | -8.04% |
2016 FY | 2790.55 Billion IDR | 15.14% |
2016 Q4 | 703.08 Billion IDR | -1.44% |
2016 Q3 | 713.38 Billion IDR | -6.84% |
2016 Q2 | 765.79 Billion IDR | 25.89% |
2015 Q3 | 648.14 Billion IDR | 5.13% |
2015 Q4 | 661.49 Billion IDR | 2.06% |
2015 FY | 2423.6 Billion IDR | 7.26% |
2015 Q1 | 497.47 Billion IDR | -30.94% |
2015 Q2 | 616.49 Billion IDR | 23.93% |
2014 Q2 | 531.21 Billion IDR | 31.19% |
2014 FY | 2259.45 Billion IDR | 15.27% |
2014 Q4 | 720.33 Billion IDR | 19.46% |
2014 Q3 | 602.98 Billion IDR | 13.51% |
2014 Q1 | 404.92 Billion IDR | -33.29% |
2013 Q1 | 388.01 Billion IDR | -22.0% |
2013 FY | 1960.06 Billion IDR | 12.25% |
2013 Q4 | 606.96 Billion IDR | 22.61% |
2013 Q3 | 495.04 Billion IDR | 5.32% |
2013 Q2 | 470.04 Billion IDR | 21.14% |
2012 Q3 | 448.83 Billion IDR | 3.8% |
2012 Q4 | 497.46 Billion IDR | 10.84% |
2012 FY | 1746.11 Billion IDR | 13.59% |
2012 Q1 | 367.4 Billion IDR | -13.78% |
2012 Q2 | 432.41 Billion IDR | 17.7% |
2011 FY | 1537.22 Billion IDR | 17.95% |
2011 Q3 | 450.66 Billion IDR | 22.82% |
2011 Q4 | 426.14 Billion IDR | -5.44% |
2011 Q2 | 366.92 Billion IDR | 25.02% |
2011 Q1 | 293.49 Billion IDR | 0.0% |
2010 FY | 1303.33 Billion IDR | 5.96% |
2009 FY | 1230.02 Billion IDR | 17.01% |
2008 FY | 1051.17 Billion IDR | 9.61% |
2007 FY | 959.03 Billion IDR | 19.15% |
2006 FY | 804.88 Billion IDR | 10.06% |
2005 FY | 731.33 Billion IDR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
PT Darya-Varia Laboratoria Tbk | 762.07 Billion IDR | -327.228% |
PT Merck Tbk | 200.74 Billion IDR | -1521.878% |
PT Phapros, Tbk | 428.44 Billion IDR | -659.91% |
PT Pyridam Farma Tbk | 293.43 Billion IDR | -1009.545% |
PT Industri Jamu dan Farmasi Sido Muncul Tbk | 827.82 Billion IDR | -293.297% |